Modern Retina

Your top destination for retina-related information. We provide insights on conditions such as age-related macular degeneration (AMD), diabetic macular edema (DME), diabetic retinopathy, uveitis, and others. We are partnered with Ophthalmology Times.

Trade/B2B

English

Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#1786791

United States

#597030

Health/Medicine

#3861

Traffic sources

Monthly visitors

Articles

RWC 2025: Companies to share data at meeting in Fort Lauderdale

1 week ago | modernretina.com | Sydney M Crago

April 17, 2025Companies working in the retina space have announced that data from clinical trials will be shared at this year’s meeting in Fort Lauderdale, Florida. Retina World Congress 2025 will take place May 8-11. As researchers prepare for their, presentation, we are highlighting the upcoming sessions that are scheduled for this meeting, which will be held in Fort Lauderdale, Florida. Note: The following list of presentations are in alphabetical order by company.
Aflibercept: Applications for dosing duration and additional indications pending decision with FDA and EMA

1 week ago | modernretina.com | Sydney M Crago

April 16, 2025A decision on a longer dosing duration for the high-dose formulation is expected by April 20, 2025. Regeneron has proposed a longer dosing duration for the high-dose (HD) formulation of aflibercept (EYLEA HD).
Effect of social media on follow-up in congenital ectopic lentis

1 week ago | modernretina.com | Lynda Charters

A new Chinese report recognized that social media smartphone application–based interventions significantly improved follow-up adherence and increased parental knowledge among families of children with congenital ectopic lentis,1 according to Yiyuan Ma, MD, who is from the State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular...
AI label system enhances training accuracy in retinal disease diagnosis

1 week ago | modernretina.com | Lynda Charters

A new Chinese study reported that an artificial intelligence (AI) reading label system was found to enhance the diagnostic accuracy of retinal diseases among ophthalmologists and holds potential for integration into future medical education,1 according to first author Meng Wang, MD, from the Department of Ophthalmology, Peking Union Medical College Hospital, and the Beijing Key Laboratory of Fundus Diseases Intelligent Diagnosis & Drug/Device Development and Translation, both in Beijing.
Enhanced OCT GA segmentation achieved with new multistage model

1 week ago | modernretina.com | Lynda Charters

A novel optical coherence tomography (OCT) retinal geographic atrophy (GA) segmentation method has been proposed by a research team from China that uses a multistage 2-branch network structure. According to coauthors Xiaoming Liu, PhD, and Jieyang Li, PhD, from the Wuhan University of Science and Technology, Wuhan, China, this method was shown to be more effective than other methods used for the GA segmentation task and for foveal avascular zone (FAZ) segmentation.
Link between fasting C-peptide and diabetic retinopathy in people with type 2 diabetes mellitus

2 weeks ago | modernretina.com | Lynda Charters

April 10, 2025Below a specific threshold, FCP exerts a protective effect, but above that threshold the protective effect becomes uncertain. A team of Chinese researchers reported that fasting C-peptide (FCP) has a complicated relationship with the development of diabetic retinopathy (DR).
FDA accepts Outlook Therapeutics' updated biologics license application for ONS-5010 to treat wet AMD

2 weeks ago | modernretina.com | Martin Harp

The US Food and Drug Administration (FDA) has accepted the resubmission of the Biologics License Application (BLA) for ONS-5010 (bevacizumab-vikg) for the treatment of wet age-related macular degeneration (AMD) from Outlook Therapeutics.1 The company previously resubmitted the BLA in February 2025.2The company noted in a press release that the FDA determined the resubmission of the BLA was a Class 2 review, which results in a 6-month review period from the date of resubmission.
Summaries generated by large language models enhance communication across different disciplines in ophthalmology

2 weeks ago | modernretina.com | Lynda Charters

The results of a large randomized, quality improvement study in the US suggested that integrating large language model (LLM)-generated plain language summaries into ophthalmology notes can improve interdisciplinary communication, although ongoing review and safety monitoring are necessary for successful clinical implementation,1 according to the first author, Prashant D. Tailor, MD.
Doctors warn TikTok & Instagram reels may be damaging eyes long-term

2 weeks ago | modernretina.com | Martin Harp

Ophthalmologists are warning about the potential negative impact short-form videos, like Instagram Reels and TikTok videos, could have on eye health.1Lalit Verma, president of the Asia Pacific Academy of Ophthalmology (APAO) congress, stressed at the conference that there is a sharp rise in patients coming in with dry eye syndrome, myopia progression, early-onset squinting, and digital eye strain, especially among the youth.
Uveitis in pediatric patients with atopic dermatitis

2 weeks ago | modernretina.com | Lynda Charters

Taiwanese investigators found in their cohort study that children with early-onset atopic dermatitis had an increased risk of developing uveitis and should be carefully observed to identify that onset.1 The study was led by Yung-Yu Chu, MD, from the Department of Ophthalmology, Chi Mei Medical Center, Tainan, Taiwan.